Gedeon Richter Plc - Company Profile
Powered by 
All the data and insights you need on Gedeon Richter Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Gedeon Richter Plc Strategy Report
- Understand Gedeon Richter Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Gedeon Richter Plc (Gedeon Richter) is a pharmaceutical company that develops, manufactures and markets a wide range of drugs including original, generic, and licensed products and over the counter (OTC) medicines. The company’s product portfolio consists of medicines to treat gynecological diseases, gastrointestinal diseases, cardiovascular diseases and central nervous system disorders. Richter’s research activities focus exclusively on the development of original small molecules, recombinant biotechnology, and generic product development. It operates sales network in Hungary, Central Eastern Europe, and the Commonwealth of Independent States (CIS) countries. The company has a research and development unit in Central Eastern Europe. Gedeon Richter is headquartered in Budapest, Hungary.
Headquarters
Hungary
Address
Gyomroi Ut 19-21., Budapest, 1103
Website
www.gedeonrichter.com/hu-hu
Telephone
36 1 4314027
No of Employees
12,167
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
RICHTER (BDP)
Revenue (2022)
$2.3B
0.3%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-6%
(2022 vs 2021)
Market Cap*
$4.6B
Net Profit Margin (2022)
XYZ
-6.3%
(2022 vs 2021)
* As of and is in US$
Gedeon Richter Plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Gynecological | Aflamin |
| Contraceptive and Emergency Contraceptive Pills | Vraylar |
| Hormone Replacement Therapy (HRT) Treatments | Evra |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In March, the company selected Trial Interactive’s eTMF platform and TI Collaborate eClinical solution for its forthcoming clinical trials. |
| 2024 | Contracts/Agreements | In March, the company signed an agreement to acquire a 50% stake in Richter-Helm BioTec GmbH & Co. KG and a 30% stake in Richter-Helm BioLogics GmbH & Co. KG. from HELM AG. |
| 2024 | Acquisitions/Mergers/Takeovers | In January, the company acquired 9.08% share capital of Formycon AG. |
Competitor Comparison
| Key Parameters | Gedeon Richter Plc | Nutex Nyrt | EGIS Pharmaceuticals Plc | PannonPharma Pharmaceutical Ltd | Polfa Hungaria Kft. |
|---|---|---|---|---|---|
| Headquarters | Hungary | Hungary | Hungary | Hungary | Hungary |
| City | Budapest | Budapest | Budapest | Pecsvarad | Budapest |
| State/Province | - | - | Central Transdanubia | Southern Transdanubia | - |
| No. of Employees | 12,167 | 1 | - | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Erik Bogsch | Chairman | Executive Board | 2017 | 76 |
| Gabor Orban | Director; Chief Executive Officer | Executive Board | 2017 | 44 |
| Gabor Gulacsi, Ph.D. | Deputy Managing Director; Director | Executive Board | 2000 | 65 |
| Gyorgy Thaler, Ph.D. | Director - Development | Senior Management | - | 64 |
| Istvan Greiner, Ph.D. | Director - Research | Senior Management | 2014 | 63 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward